TY - JOUR
T1 - Contributions of the international plant science community to the fight against human infectious diseases – part 1
T2 - epidemic and pandemic diseases
AU - Lobato Gómez, Maria
AU - Huang, Xin
AU - Alvarez, Derry
AU - He, Wenshu
AU - Baysal, Can
AU - Zhu, Changfu
AU - Armario-Najera, Victoria
AU - Blanco Perera, Amaya
AU - Cerda Bennasser, Pedro
AU - Saba-Mayoral, Andera
AU - Sobrino-Mengual, Guillermo
AU - Vargheese, Ashwin
AU - Abranches, Rita
AU - Abreu, Isabel Alexandra
AU - Balamurugan, Shanmugaraj
AU - Bock, Ralph
AU - Buyel, Johannes F.
AU - da Cunha, Nicolau B.
AU - Daniell, Henry
AU - Faller, Roland
AU - Folgado, André
AU - Gowtham, Iyappan
AU - Häkkinen, Suvi T.
AU - Kumar, Shashi
AU - Ramalingam, Sathish Kumar
AU - Lacorte, Cristiano
AU - Lomonossoff, George P.
AU - Luís, Ines M.
AU - Ma, Julian K.C.
AU - McDonald, Karen A.
AU - Murad, Andre
AU - Nandi, Somen
AU - O’Keef, Barry
AU - Oksman-Caldentey, Kirsi Marja
AU - Parthiban, Subramanian
AU - Paul, Mathew J.
AU - Ponndorf, Daniel
AU - Rech, Elibio
AU - Rodrigues, Julio C.M.
AU - Ruf, Stephanie
AU - Schillberg, Stefan
AU - Schwestka, Jennifer
AU - Shah, Priya S.
AU - Singh, Rahul
AU - Stoger, Eva
AU - Twyman, Richard M.
AU - Varghese, Inchakalody P.
AU - Vianna, Giovanni R.
AU - Webster, Gina
AU - Wilbers, Ruud H.P.
AU - Capell, Teresa
AU - Christou, Paul
PY - 2021/10
Y1 - 2021/10
N2 - Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccination programmes, hygiene measures and drugs that suppress the pathogen, treat the disease symptoms or attenuate aggressive reactions of the host immune system. The provision of vaccines and biologic drugs such as antibodies is hampered by the high cost and limited scalability of traditional manufacturing platforms based on microbial and animal cells, particularly in developing countries where infectious diseases are prevalent and poorly controlled. Molecular farming, which uses plants for protein expression, is a promising strategy to address the drawbacks of current manufacturing platforms. In this review article, we consider the potential of molecular farming to address healthcare demands for the most prevalent and important epidemic and pandemic diseases, focussing on recent outbreaks of high-mortality coronavirus infections and diseases that disproportionately affect the developing world.
AB - Infectious diseases, also known as transmissible or communicable diseases, are caused by pathogens or parasites that spread in communities by direct contact with infected individuals or contaminated materials, through droplets and aerosols, or via vectors such as insects. Such diseases cause ~17% of all human deaths and their management and control places an immense burden on healthcare systems worldwide. Traditional approaches for the prevention and control of infectious diseases include vaccination programmes, hygiene measures and drugs that suppress the pathogen, treat the disease symptoms or attenuate aggressive reactions of the host immune system. The provision of vaccines and biologic drugs such as antibodies is hampered by the high cost and limited scalability of traditional manufacturing platforms based on microbial and animal cells, particularly in developing countries where infectious diseases are prevalent and poorly controlled. Molecular farming, which uses plants for protein expression, is a promising strategy to address the drawbacks of current manufacturing platforms. In this review article, we consider the potential of molecular farming to address healthcare demands for the most prevalent and important epidemic and pandemic diseases, focussing on recent outbreaks of high-mortality coronavirus infections and diseases that disproportionately affect the developing world.
KW - COVID-19
KW - HIV/AIDS
KW - Molecular farming
KW - plant-made pharmaceuticals
KW - SARS-CoV-2
KW - Humans
KW - Communicable Diseases/epidemiology
KW - Pandemics/prevention & control
UR - http://www.scopus.com/inward/record.url?scp=85110534295&partnerID=8YFLogxK
U2 - 10.1111/pbi.13657
DO - 10.1111/pbi.13657
M3 - Review Article
C2 - 34182608
AN - SCOPUS:85110534295
SN - 1467-7644
VL - 19
SP - 1901
EP - 1920
JO - Plant Biotechnology Journal
JF - Plant Biotechnology Journal
IS - 10
ER -